Guru Ownership Trend
Guru Analysis for Eledon Pharmaceuticals, Inc. (ELDN)
Eledon Pharmaceuticals, Inc. (ELDN), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 3 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $5.08 M.
Top institutional holders include Jefferies Group and Cliff Asness.
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $1.62 M net outflow during the quarter.
Recent activity highlights Cliff Asness who increased their stake by 186.3%. Conversely, Renaissance Technologies (RenTech) reduced exposure by 86.1%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for Eledon Pharmaceuticals, Inc. (ELDN)
Major holders include Jefferies Group ($3.37 M), Cliff Asness ($531,045), Renaissance Technologies (RenTech) ($75,768). According to the latest reported data, 3 tracked investment managers collectively hold approximately 1.29 M shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $1.62 M, with 1 managers increasing positions and 2 managers reducing holdings.
During the most recent reporting period, 2 managers trimmed their positions, while 0 fully exited ELDN. The total reported sell value was $1.97 M.
Yes, 0 managers opened new positions in ELDN, and 1 increased their existing holdings. The total reported buy value was $345,582.58.